Company Encyclopedia
View More
name
PKU HEALTHCARE
000788.SZ
PKU HealthCare Corp.,Ltd. engages in the research and development, production, and sale of chemical pharmaceutical preparations, pharmaceutical distribution, and medical services in China. The company offers products in various categories, including cardiovascular and cerebrovascular, antimicrobial, antipyretic and analgesic, digestive system, oncology, anti-allergic, blood sugar and immunity regulation, mental disorder, and blood volume expansion. It also provides tumor screening, health management, diagnosis, and treatment services.
3.159 T
000788.SZMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
PharmaceuticalsIndustry
Industry Ranking157/223
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE9.11%B
    • Profit Margin8.17%B
    • Gross Margin31.24%C
  • Growth ScoreD
    • Revenue YoY-15.24%E
    • Net Profit YoY11.69%C
    • Total Assets YoY-9.83%E
    • Net Assets YoY5.08%B
  • Cash ScoreC
    • Cash Flow Margin1223.38%B
    • OCF YoY-15.24%E
  • Operating ScoreB
    • Turnover0.79B
  • Debt ScoreA
    • Gearing Ratio23.09%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    A-shares closing: The ChiNext index opened lower but rose over 2%, with the consumer sector strengthening in the closing minutes

    The A-shares closed today with the ChiNext Index opening low and rising over 2%, while the consumer sector strengthened towards the end of trading. The Shanghai Composite Index fluctuated within a narrow range throughout the day, closing down 0.15%; the Shenzhen Component Index rose 1.02%; the ChiNext Index increased by 2.14%. Pharmaceutical stocks were strong, with GUANGJI PHARMA and PKU HEALTHCARE hitting the daily limit. CPO and other computing hardware stocks performed well, with Zhongji Xuchuang soaring over 10%. The consumer sector surged towards the end, with GUOGUANG CHAINS and Sanjiang Shopping Club hitting the daily limit. The military industry sector collectively adjusted, with Jiuzhiyang and Jianglong Shipbuilding dropping over 10%. Most individual stocks fell rather than rose, with over 3,500 stocks in the Shanghai, Shenzhen, and Beijing markets showing losses, and the trading volume nearing 1.8 trillion

    Wallstreetcn·
    SZ
    000952
    -6.85%
    SZ
    000788
    -2.26%
    SH
    605188
    +0.60%
    Wallstreetcn·
    SZ
    000952
    -6.85%
    SZ
    000788
    -2.26%
    SH
    605188
    +0.60%

    PKU HEALTHCARE released its performance for the first three quarters, with a net profit attributable to the parent company of 136 million yuan, an increase of 4.31%

    According to the Zhitong Finance APP, PKU HEALTHCARE released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 1.231 billion yuan, a year-on-year decrease of 19.76%. The net profit attributable to shareholders of the listed company was 136 million yuan, a year-on-year increase of 4.31%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 126 million yuan, a year-on-year decrease of 2.66%. The basic earnings per share were 0.2282 yuan

    Zhitong·
    SZ
    000788
    -2.26%
    Zhitong·
    SZ
    000788
    -2.26%

    PKU HEALTHCARE: Chairman and President Xu Xiren has been criminally detained

    According to the Zhitong Finance APP, PKU HEALTHCARE announced that the company recently received a notification from relevant authorities, informing that the company's chairman and president Xu Xiren has been criminally detained and is currently cooperating with the investigation by relevant departments, making it temporarily impossible for him to perform his duties normally. At present, the company has made proper arrangements for related work, the company's control has not changed, the board of directors is operating normally, and the company's financial and production management situation is normal

    Zhitong·
    SZ
    000788
    -2.26%
    Zhitong·
    SZ
    000788
    -2.26%

    PKU HEALTHCARE has obtained the drug registration certificate for Apremilast Tablets

    PKU HEALTHCARE has obtained the drug registration certificate for Apremilast tablets issued by the National Medical Products Administration, which includes specifications of 10mg and 30mg. Apremilast is a small molecule inhibitor targeting PDE4, primarily used for the treatment of moderate to severe plaque psoriasis, with advantages such as rapid onset, clear efficacy, and high safety

    Zhitong·
    SZ
    000788
    -2.26%
    Zhitong·
    SZ
    000788
    -2.26%

    PKU HEALTHCARE's wholly-owned subsidiary has been renamed, changed its legal representative, and completed industrial and commercial registration

    PKU HEALTHCARE Co., Ltd. announced that its wholly-owned subsidiary "Beijing Beiyi Pharmaceutical Co., Ltd." has been renamed to "Beijing New Advantage Pharmaceutical Commercial Co., Ltd." The legal representative has changed from Yuan Pingdong to Cheng Hong, and the industrial and commercial change registration has been completed, obtaining a new business license. The new company has a registered capital of 100 million yuan, established on June 10, 1998, and its business scope includes pharmaceutical wholesale and medical device sales, among others

    Zhitong·
    SZ
    000788
    -2.26%
    Zhitong·
    SZ
    000788
    -2.26%
    © 2025 Longbridge｜Disclaimer